A Supponive, Prospective, Multicenter, Double-BIind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of MK-0826 Versus Ceftriaxone Sodium in the Treatment of Serious Community-Acquired Pneumonia in Adults

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2000
This article has no abstract
Epistemonikos ID: 6b6f1dee41a9b80e07e2c86a15723ed7eb1b189a
First added on: Apr 16, 2025